ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
685
Employees685
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
685
Employees685

ADMA Key Statistics

Market cap
4.16B
Market cap4.16B
Price-Earnings ratio
20.32
Price-Earnings ratio20.32
Dividend yield
Dividend yield
Average volume
2.12M
Average volume2.12M
High today
$17.61
High today$17.61
Low today
$17.06
Low today$17.06
Open price
$17.14
Open price$17.14
Volume
1.91M
Volume1.91M
52 Week high
$25.67
52 Week high$25.67
52 Week low
$13.50
52 Week low$13.50

Stock Snapshot

With a market cap of 4.16B, ADMA Biologics(ADMA) trades at $17.50. The stock has a price-to-earnings ratio of 20.32.

On 2026-02-03, ADMA Biologics(ADMA) stock moved within a range of $17.06 to $17.61. With shares now at $17.50, the stock is trading +2.6% above its intraday low and -0.6% below the session's peak.

Trading volume for ADMA Biologics(ADMA) stock has reached 1.91M, versus its average volume of 2.12M.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.

ADMA News

Simply Wall St 5d
A Look At ADMA Biologics Valuation After Strong Analyst Support And Growing Interest In Its Therapies

Fresh investor attention on ADMA Biologics (ADMA) follows recent commentary highlighting analyst support and interest in its plasma derived therapies for primar...

A Look At ADMA Biologics Valuation After Strong Analyst Support And Growing Interest In Its Therapies

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.